Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4095299 | 0.86 | IDO1 (0.40) | TDP1LMNAIDO1MAPTL3MBTL1 | |
| SCHEMBL4375537 | 0.80 | TDP1 (0.54) | TDP1LMNAMAPTL3MBTL1ATM | |
| SCHEMBL24843578 | 0.77 | GAA (0.36) | TDP1LMNAIDO1MAPTL3MBTL1 | |
| SCHEMBL31042956 | 0.75 | IDO1 (0.34) | IDO1TLR8 | |
| SCHEMBL7157400 | 0.75 | LMNA (0.41) | LMNAIDO1KDM4EMEN1KMT2A | |
| SCHEMBL20421684 | 0.74 | TLR8 (0.44) | TDP1LMNAIDO1KDM4EKMT2A | |
| SCHEMBL23148122 | 0.73 | KDM4E (0.34) | TDP1LMNAMAPTL3MBTL1GAA | |
| SCHEMBL30056734 | 0.72 | TDP1 (0.48) | TDP1LMNAMAPTL3MBTL1ATM | |
| SCHEMBL27383078 | 0.72 | TDP1 (0.48) | TDP1LMNAMAPTL3MBTL1ATM | |
| Bromide SCHEMBL7622502 | 0.70 | TDP1 (0.46) | TDP1LMNAMAPTL3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1453377-A1 | HERBICIDES BASED ON SUBSTITUTED CARBOXYLIC ACID ANILIDES | Bayer CropScience AG (DE) | 2004-09-08 | — | — | EP | claimed |
| EP-1423005-A1 | HERBICIDAL MIXTURES BASED ON SUBSTITUTED ARYL KETONES | Bayer CropScience AG (DE) | 2004-06-02 | — | — | EP | claimed |
| EP-1351571-A2 | SELECTIVE HERBICIDES BASED UPON 2,6-DISUBSTITUTED PYRIDINE DERIVATIVES | Bayer CropScience AG (DE) | 2003-10-15 | — | — | EP | claimed |
| WO-2003047346-A1 | HERBICIDES BASED ON SUBSTITUTED CARBOXYLIC ACID ANILIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-06-12 | — | — | WO | claimed |
| WO-2003020033-A1 | HERBICIDAL MIXTURES BASED ON SUBSTITUTED ARYL KETONES | BAYER CROPSCIENCE AG (DE) | 2003-03-13 | — | — | WO | claimed |
| WO-2001035740-A2 | SELECTIVE HERBICIDES BASED UPON 2,6-DISUBSTITUTED PYRIDINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-25 | — | — | WO | claimed |
| US-20230357155-A1 | IMPROVED SYNTHESIS OF 4-AMINO-6-(HETEROCYCLIC)PICOLINATES | CORTEVA AGRISCIENCE LLC (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230174490-A1 | IMPROVED SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES | CORTEVA AGRISCIENCE LLC (US) | 2023-06-08 | — | — | US | disclosed |
| WO-2023092188-A1 | \"COMPOUNDS AND METHODS\ | DemAgtech Pty Ltd (AU) | 2023-06-01 | — | — | WO | disclosed |
| WO-2020253696-A1 | SUBSTITUTED PYRIDINEMETHYLENE PYRIDINECARBOXYLATE DERIVATIVE, PREPARATION METHOD THEREFOR AND HERBICIDAL COMPOSITION AND USE THEREOF | 青岛清原化合物有限公司 | 2020-12-24 | — | — | WO | disclosed |
| EP-1351571-A2 | SELECTIVE HERBICIDES BASED UPON 2,6-DISUBSTITUTED PYRIDINE DERIVATIVES | Bayer CropScience AG (DE) | 2003-10-15 | — | — | EP | disclosed |
| WO-2001035740-A2 | SELECTIVE HERBICIDES BASED UPON 2,6-DISUBSTITUTED PYRIDINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357155-A1 | IMPROVED SYNTHESIS OF 4-AMINO-6-(HETEROCYCLIC)PICOLINATES | APC, PPOX, ALAD | TDP1 1950/4885LMNA 2579/4885IDO1 1581/4885 |
| US-20230174490-A1 | IMPROVED SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES | AAAS, AADAC, NPEPPS | TDP1 3412/4885LMNA 4149/4885IDO1 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.